shareholdersunite.com

Opportunities in smallcaps

shareholdersunite.com header image 2

InfuSystem Will Benefit From Tailwinds, But It Is Low On Cash

September 6th, 2019 · No Comments

  • The company is on a growth path due to increased incidence of colorectal cancer.
  • Add to this, a windfall from a competitor winding down and revenue growth is accelerating and will accelerate more in H2 and next year.
  • This will produce operational leverage and next year a substantial reduction in CapEx, so profit growth is likely to be brisk.
  • We don’t think this sound prospect is fully reflected in the share price.

Source: InfuSystem Will Benefit From Tailwinds, But It Is Low On Cash – InfuSystem Holdings Inc. (NYSEMKT:INFU) | Seeking Alpha

Tags: INFU